Horizon Pharma (HZNP) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Horizon Pharma plc Announces Record Second Quarter 2015 Financial Results
August 7, 2015 7:00 AM EDTDUBLIN, IRELAND -- (Marketwired) -- 08/07/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced its second-quarter 2015 financial results today.
Quarterly Financial Highlights
(in millions except for per share amounts and % % percentages) Q2 15 Q2 14 Change 1H 15 1H 14 Change ------- ------- ------ ------- ------- ------ Net sales $ 172.8 $ 66.1 161 $ 286.0 $ 118.0 142 Net income (loss) 31.8 (27.8) NM 12.3 (234.0) NM Adjusted non-GAAP net income 61.9 19.8 213 86.4 26.8 222 Adjusted EBITDA 76.1 21.5 254 108.5 30.2 259 Earnings (loss) per share - basic $ 0.21 $ (0.38) NM $ 0.09 $ (3.34) NM Adjusted non-GAAP earnings per share - basic 0.41 0.27 52 0.62 0.38 63 Earnings (loss)... More
Depomed Sends Letter to Horizon Pharma
August 7, 2015 6:30 AM EDTNEWARK, Calif., Aug. 7, 2015 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today announced that it has sent the following letter to Horizon Pharma plc (NASDAQ: HZNP) ("Horizon"):
August 7, 2015
Timothy P. Walbert Chairman of the Board, President and Chief Executive OfficerHorizon Pharma plcConnaught House, 1st Floor, 1 Burlington Road Dublin 4, IrelandÂ
Dear Tim, Â
In our... More
